1. Home
  2. HMNF vs IVA Comparison

HMNF vs IVA Comparison

Compare HMNF & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HMNF
  • IVA
  • Stock Information
  • Founded
  • HMNF 1934
  • IVA 2011
  • Country
  • HMNF United States
  • IVA France
  • Employees
  • HMNF N/A
  • IVA N/A
  • Industry
  • HMNF Savings Institutions
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HMNF Finance
  • IVA Health Care
  • Exchange
  • HMNF Nasdaq
  • IVA Nasdaq
  • Market Cap
  • HMNF 125.8M
  • IVA 117.3M
  • IPO Year
  • HMNF 1994
  • IVA 2020
  • Fundamental
  • Price
  • HMNF $27.99
  • IVA $1.65
  • Analyst Decision
  • HMNF
  • IVA Strong Buy
  • Analyst Count
  • HMNF 0
  • IVA 3
  • Target Price
  • HMNF N/A
  • IVA $18.00
  • AVG Volume (30 Days)
  • HMNF 12.9K
  • IVA 12.9K
  • Earning Date
  • HMNF 10-17-2024
  • IVA 09-25-2024
  • Dividend Yield
  • HMNF 1.39%
  • IVA N/A
  • EPS Growth
  • HMNF N/A
  • IVA N/A
  • EPS
  • HMNF 1.19
  • IVA N/A
  • Revenue
  • HMNF $38,260,000.00
  • IVA $20,652,523.00
  • Revenue This Year
  • HMNF N/A
  • IVA N/A
  • Revenue Next Year
  • HMNF N/A
  • IVA $469.85
  • P/E Ratio
  • HMNF $24.03
  • IVA N/A
  • Revenue Growth
  • HMNF N/A
  • IVA N/A
  • 52 Week Low
  • HMNF $17.60
  • IVA $1.53
  • 52 Week High
  • HMNF $29.40
  • IVA $4.75
  • Technical
  • Relative Strength Index (RSI)
  • HMNF 58.59
  • IVA 29.90
  • Support Level
  • HMNF $26.60
  • IVA $1.77
  • Resistance Level
  • HMNF $28.11
  • IVA $1.92
  • Average True Range (ATR)
  • HMNF 0.66
  • IVA 0.12
  • MACD
  • HMNF 0.11
  • IVA -0.03
  • Stochastic Oscillator
  • HMNF 62.80
  • IVA 18.00

About HMNF HMN Financial Inc.

HMN Financial Inc is a stock savings bank holding company of Home Federal Savings Bank. The bank is engaged in community banking and operates retail banking and loan production facilities in Minnesota, Iowa, and Wisconsin. It is involved in the business of attracting deposits from the general public and businesses and using such deposits to originate single-family residential, commercial real estate, and multi-family mortgage loans as well as consumer, construction, and commercial business loans. The bank also invests in mortgage-backed and related securities, U.S. government agency obligations, and other permissible investments. Its products and services include checking and savings accounts, cash deposits, online services, and credit cards among others.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: